# Thoracoscopic Ablation for Lone Atrial Fibrillation

Study · id `cardio:ct-nct05708027` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05708027](<https://clinicaltrials.gov/study/NCT05708027>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05708027

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 232 participants.

## Technical summary

Registry record NCT05708027. Non-randomized; no masking; primary purpose treatment. Start 2021-01-06 (actual); primary completion 2022-08-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 232 participants (enrolled count; ClinicalTrials.gov record NCT05708027, source copy `cardio:ctgov-nct05708027-2023-02-01`, retrieved 2026-10-26)
- Started: 2021-01-06 (actual) (ClinicalTrials.gov record NCT05708027, source copy `cardio:ctgov-nct05708027-2023-02-01`, retrieved 2026-10-26)
- Primary completion: 2022-08-31 (actual) (ClinicalTrials.gov record NCT05708027, source copy `cardio:ctgov-nct05708027-2023-02-01`, retrieved 2026-10-26)
- Completion: 2023-09-30 (anticipated) (ClinicalTrials.gov record NCT05708027, source copy `cardio:ctgov-nct05708027-2023-02-01`, retrieved 2026-10-26)
- Countries: Russia (ClinicalTrials.gov record NCT05708027, source copy `cardio:ctgov-nct05708027-2023-02-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05708027-2023-02-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Thoracoscopic Ablation for Lone Atrial Fibrillation
- Condition: Atrial Fibrillation
- Condition: Heart Diseases
- Intervention (Procedure): Thoracoscopic surgical ablation
- Lead sponsor: Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
- Lead sponsor class: OTHER\_GOV
- Collaborator: Federal State Budget Institution Clinical Hospital, Moscow, Russia
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

## Provenance

Content hash: beeabffacbe2a213fbffd94f8e1d6a5d80935a7f6147d28716e4265e01b621ed
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
